Biosample Breakthroughs: The Hidden Ingredients Behind Every Drug You've Ever Taken

The headline’s “hidden ingredients” are a metaphor. Human biosamples are not ingredients in finished medicines. They are samples—such as blood, tissue, or other biological material—that researchers may study to learn how living systems work and how they vary from person to person.

A sample can offer a window into a particular biological process. Researchers use carefully designed studies to examine cells, molecules, and other features, then compare findings across samples. This can help them investigate what is shared, what differs, and which questions deserve closer attention.

That variation matters in drug discovery. A biological target or response observed in one setting may not tell the whole story. Studying samples from different people and contexts can help researchers explore how biological differences might affect a disease process or a potential treatment approach.

Biosamples can support many stages of research, from building a clearer picture of a condition to investigating whether a proposed therapy acts on its intended target. Their value depends on the research question, the quality and context of the samples, and responsible study design. A sample alone does not prove that a treatment will work or be safe.

Researchers may also use these insights to investigate more personalized approaches to therapy. By studying patterns of biological variation, they can ask whether certain mechanisms or responses differ among groups of people. Such findings are part of an evolving research process, not a guarantee that a treatment can be matched to any individual.

The path from a research sample to a medicine is neither automatic nor universal. Discoveries need further testing and evaluation, and medicines are developed through many kinds of evidence and research. Biosamples are one important way to ask better questions about human biology—and, sometimes, to help guide what researchers investigate next.

Introducing: Biosample Breakthroughs, a new series from ePluribus Health exploring the importance of biosamples in the discovery of new, game changing drug therapies

Every drug you’ve ever taken exists because somewhere along the way, a piece of human biology, whether a blood draw, a tumor biopsy, or a vial of saliva, ended up on a lab bench. 

We don’t talk about that enough.

Through many conversations, I have come to realize that the vast majority of people don't even have the most basic understanding of what a biosample is, how they are acquired, what consent is provided or how they are used in research and discovery. It is my hope, that I can convey some of the critical importance of biosamples in early stage R&D to enable game changing drug discovery and innovation. But let's start with some basic defintions:

What is a biosample?
A biosample is any biological material collected for diagnostics and/or research: blood/plasma/serum, tissue biopsies, bone marrow, cerebrospinal fluid, saliva, urine, swabs, or cultured patient cells (including iPSCs). Simple materials, outsized impact.

Why they matter?
Researchers can’t design a drug for a disease they don’t understand at the molecular level. Biosamples let researchers:
    •    Find the target - what gene or protein is actually driving the disease
    •    Validate it - does turning it off actually help, before spending a decade on a drug
    •    Test the drug - does it work in real human tissue, not just mice
    •    Select the right patients - precision medicine starts with a biopsy

The hard part
Every sample comes from a real person, often at their hardest moment. Add rare-disease scarcity, invasive collection procedures, cold-chain logistics, historical diversity gaps in biobanks, and cross-border regulation, and you start to see why “just get a sample” is never actually simple.

Over the next few weeks, I’m tracing 25 drugs back to the specific biosamples that made them possible. I will share what was collected, how it was used, and why the drug couldn’t exist without it. First up: Gleevec, the Chromosome that Named its Own Drug.

Follow along!

Comments

Leave a Reply